Canton Hathaway’s Gilead Sciences GILD Stock Holding History

Canton Hathaway’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$43.6K	Hold	345	–	–	0.01%	216
2026 Q1	$48.1K	Hold	345	–	–	0.01%	195
2025 Q4	$42.3K	Hold	345	–	–	0.01%	212
2025 Q3	$38K	Hold	345	–	–	0.01%	225
2025 Q2	$38K	Hold	345	–	–	0.01%	219
2025 Q1	$39K	Hold	345	–	–	0.01%	217
2024 Q4	$32K	Hold	345	–	–	0.01%	197
2024 Q3	$29K	Hold	345	–	–	0.01%	211
2024 Q2	$24K	Hold	345	–	–	0.01%	221
2024 Q1	$25K	Hold	345	–	–	0.01%	220
2023 Q4	$28K	Hold	345	–	–	0.01%	204
2023 Q3	$26K	Hold	345	–	–	0.01%	202
2023 Q2	$27K	Hold	345	–	–	0.01%	202
2023 Q1	$29K	Hold	345	–	–	0.01%	186
2022 Q4	$30K	Hold	345	–	–	0.01%	191
2022 Q3	$21K	Hold	345	–	–	0.01%	212
2022 Q2	$21K	Buy	+345	New	+$21.4K	0.01%	245
2022 Q1	–	Sell	-345	Closed	-$25K	–	251
2021 Q4	$25K	Hold	345	–	–	0.01%	264
2021 Q3	$24K	Buy	+345	New	+$24.2K	0.01%	265
2020 Q2	–	Sell	-564	Closed	-$42K	–	162
2020 Q1	$42K	Buy	+564	New	+$39K	0.03%	101

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Canton Hathaway's GILD Position: Q2 2026 in Review

Canton Hathaway held its Gilead Sciences (GILD) position steady in Q2 2026 at 345 shares worth $43.6K. The position accounts for 0.01% of the portfolio, ranked #216.

Canton Hathaway first reported a position in GILD in Q1 2020 and has held it in 20 quarters since. The position peaked at $48.1K in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Canton Hathaway held 345 shares of Gilead Sciences worth $43.6K as of Q2 2026.
Canton Hathaway left its Gilead Sciences share count unchanged in Q2 2026.
Gilead Sciences made up 0.01% of Canton Hathaway's portfolio in Q2 2026, its #216 holding.
Canton Hathaway first reported a position in Gilead Sciences in Q1 2020 and has held it in 20 quarters since.
Canton Hathaway's Gilead Sciences position peaked at $48.1K in Q1 2026.
2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Canton Hathaway's 13F filing for Q2 2026, filed 6 Aug 2026.